Skip to Content

'
Krina Patel

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

 

My research focus is on improving therapy and outcomes for patients with multiple myeloma and other plasma cell dyscrasias.

 

My specific research interests include:

1.       Multiple Myeloma and other plasma cell dyscrasia (i.e. POEMS, Waldenstrom’s macroglobulinemia,

          Plasmablastic lymphoma, Amyloid).

2.       Developing cellular therapy such as CAR T cells with or without transplant.

3.       Combining immunotherapy and chemotherapy in the transplant setting.

Education & Training

Degree-Granting Education

2007 The University of Texas Southwestern Medical Center, Dallas, TX, MD, Medical Doctor
2003 University of Pennsylvania, Philadelphia, PA, BA, Double Major in Biological Basis of Behavior and South Asian Regional Studies

Postgraduate Training

7/2013-2014 Chief Fellow, M.D. Anderson Cancer Center, Houston, TX
7/2012-2013 Chief Fellow for Resident Education, M.D. Anderson Cancer Center, Houston, TX
7/2011-6/2014 Clinical Fellowship, Hematology/Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX
7/2010-6/2011 Chief Resident, The University of Texas Health Science Center (UT Health), Houston, TX
7/2007-6/2010 Clinical Residency, Internal Medicine Residency, The University of Texas Health Science Center (UTHealth), Houston, TX

Board Certifications

11/2014 American Board of Internal Medicine - Medical Oncology
11/2014 American Board of Internal Medicine - Hematology
8/2010 American Board of Internal Medicine - Internal Medicine

Experience/Service

Academic Appointments

Assistant Chief of Service, Division of Internal Medicine, The University of Texas UT Health IM Residency, Houston, TX, 2010-2011

Institutional Committee Activities

Student Member, GSBS Masters in Patient Based Research Committee, 7/2013-present
Member, Acute & Critical Care Subcommittee, 2012-present

Honors and Awards

2014 2014 Participant Clinical Trial Methods and Design Workshop, MD Anderson Cancer Center
2012 AACR/ASCO Workshop Methods in Clinical Research 2012, AACR/ASCO
2012 ASCO Annual Meeting Merit Travel Award, ASCO
2011-2012 Clifton D. Howe Award for Clinical Excellence, The University of Texas M.D. Anderson Cancer Center
2010-2011 Unparalleled Performance as Chief Medical Resident, Herb Fred, MD

Professional Memberships

American Association for Cancer Research (AACR)
Member, 1/2014-present
American Society for Blood and Marrow Transplantation (ASBMT)
Member, 11/2014-present
American Society of Clinical Oncology (ASCO)
Member, 1/2012-present
American Society of Hematology (ASH)
Member, 1/2012-present
The Herb Fred Medical Society, Houston, TX
Member, 10/2011-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Patel K, Nusrat M, Shah N, Bashir Q, Parmar S, Shah J, Thomas S, Weber D, Orlowski RZ, Champlin R, Qazilbash MH. Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome. Bone Marrow Transplant 49(3):465-6, 3/2014. e-Pub 1/2014. PMID: 24419515.
2. Menon C, Bauer TW, Kelley ST, Raz DJ, Bleier JI,Patel K, Steele K, Prabakaran I, Shifrin A, Buerk DG, Sehgal CM, Fraker DL. Tumoricidal activity of high-dose tumor necrosis factor-alpha is mediated by macrophage-derived nitric oxide burst and permanent blood flow shutdown. Int J Cancer 123(2):464-75, 7/2008. PMID: 18449880.

Abstracts

1. Patel K, Olivares S, Hurton, L, Huls H, Qazilbash M, Champlin R, Cooper LJN. T-Cell Therapy for Multiple Myeloma Using NY-ESO-1+ T-Cell Antigen Presenting Cells (T-APC) Combined with Adoptive Cellular Transfer (ACT) to Augment Immunotherapy. ASH 2014, 11/2014.
2. Patel K, Orlowski R, Qazilbash M, Shah J. Plasmablastic lymphoma: 28 patient single institution experience. ASH 2013, 12/2013.
3. Patel K, Qazilbash M. Prognostic role of serum lactate dehydrogenase (LDH) prior to autologous stem cell transplant in Multiple Myeloma. ASH 2012, 12/2012.
4. Khan D, Patel K, Qazilbash M. Feasibility of Hematopoietic Stem Cell Collection and Cryopreservation in Waldenstrom’s Macroglobulinemia. ASH 2012, 11/2012.
5. Patel K, Saliba R, Qazilbash M. Autologous stem cell transplantation in Waldenstroms Macroglobulinemia. 2012 International Workshop on Waldenstrom's macroglobulinemia and Multiple Myeloma Symposium. 9/2012.
6. Patel K, Delasalle K, Orlowski R. Prognositic value of serum lactate dehydrogenase in symptomatic myeloma. ASCO 2012, 11/2011.
7. Koranne K, Patel K, Escobar M. Escobar M. Acquired Factor VIII inhibitor: a rare complication of Primary Biliary Cirrhosis. ACP Annual Meeting, 10/2011.

Grant & Contract Support

Title: NY-ESO-1+ T-APC in High Risk Multiple Myeloma
Funding Source: Myeloma SPORE CDP
Role: Principal Investigator
Duration: 9/1/2013 - 8/31/2014

Last updated: 12/30/2014